about
Characterization of Human Cancer Cell Lines by Reverse-phase Protein ArraysPharmacodynamic characterization of the efficacy signals due to selective BRAF inhibition with PLX4032 in malignant melanoma.Antitumor effects of the investigational selective MEK inhibitor TAK733 against cutaneous and uveal melanoma cell lines.Differential sensitivity of melanoma cell lines with BRAFV600E mutation to the specific Raf inhibitor PLX4032.
P4510
Q54903527-8E39450E-8744-49B6-B12A-E073FCCA8271Q54903528-42EA51F0-84C7-4318-9BF1-71C1894A446EQ54903529-363D5D18-227E-4516-BA0F-B10538E9A7C3Q54903530-113978BE-9C7E-4FF7-BD36-CB105DCBEBB8Q54903531-22E8E0CE-5C4F-4AD3-AE9E-1E78AC67667EQ54903532-19AB8528-02E8-49F3-B5C2-8652C7458E54Q54903533-F43E3EDA-2519-49C1-BF11-19AB9FD8473CQ54903534-BB3D1B85-987F-4A5A-A4B0-96F510F4BD13Q54903535-923BE6A1-BA78-4E87-8403-808F9465E084Q54903536-2D71741D-2BFD-4802-9D7B-BB821B4079B5Q54903537-E26FBF21-CB2A-4131-9CA2-8AA8FF83E8D2Q54903538-0CDE3D2E-1EA4-4CE0-BDBE-FFA31D3237D9Q54903539-BE0C83F4-61D0-4E47-AB03-F310843D59E7Q54903540-28853A1E-C2CD-48B0-8AE5-28A3D4D69788Q54903541-45DCB67A-88E4-49CB-83D9-E929544A252BQ54903542-8516E230-8E96-4AD5-B5D0-6C825C1BBCA9Q54903543-EA71AC6E-5B11-429A-B9A4-675072287AA4
P3432
description
Zelllinie
@de
ceall-líne
@ga
cell line
@en
cellijn van een Homo sapiens
@nl
lignée cellulaire
@fr
linhagem celular
@pt
name
M229
@de
M229
@en
M229
@fr
M229
@ga
M229
@nl
M229
@pt
type
label
M229
@de
M229
@en
M229
@fr
M229
@ga
M229
@nl
M229
@pt
prefLabel
M229
@de
M229
@en
M229
@fr
M229
@ga
M229
@nl
M229
@pt